Rep. Gilbert Ray Cisneros, Jr. Sells ICU Medical, Inc. (NASDAQ:ICUI) Stock

Key Points

• Representative Gilbert Ray Cisneros, Jr. sold shares of ICU Medical, Inc. for between $1,001 and $15,000 on May 6th, which was part of a larger pattern of stock trading involving multiple companies.
• ICU Medical's most recent earnings report indicated a quarterly revenue of $599.49 million, exceeding analysts' expectations and showing a 6.7% increase compared to the same quarter last year.
• Insider trading activity at ICU Medical has included significant sales by directors, with insiders offloading over 36,000 shares valued at nearly $4.9 million in the last 90 days.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of ICU Medical, Inc. (NASDAQ:ICUI). In a filing disclosed on June 06th, the Representative disclosed that they had sold between $1,001 and $15,000 in ICU Medical stock on May 6th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of SpringWorks Therapeutics NASDAQ: SWTX on 7/1/2025.
• Purchased $1,001 - $15,000 in shares of AppLovin NASDAQ: APP on 7/1/2025.
• Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 6/30/2025.
• Purchased $1,001 - $15,000 in shares of CoStar Group NASDAQ: CSGP on 6/30/2025.
• Purchased $15,001 - $50,000 in shares of CoStar Group NASDAQ: CSGP on 6/27/2025.
• Purchased $1,001 - $15,000 in shares of Xiaomi OTCMKTS: XIACF on 6/27/2025.
• Sold $1,001 - $15,000 in shares of ASML NASDAQ: ASML on 6/27/2025.
• Sold $1,001 - $15,000 in shares of Willis Towers Watson Public NASDAQ: WTW on 6/26/2025.
• Sold $1,001 - $15,000 in shares of Boston Scientific NYSE: BSX on 6/26/2025.
• Sold $1,001 - $15,000 in shares of Liberty Media Corporation - Liberty Formula One Series C NASDAQ: FWONK on 6/26/2025.

ICU Medical Price Performance

Shares of ICUI stock traded down $0.01 during mid-day trading on Tuesday, hitting $127.49. 46,947 shares of the stock traded hands, compared to its average volume of 249,598. ICU Medical, Inc. has a twelve month low of $117.92 and a twelve month high of $196.26. The firm has a market cap of $3.14 billion, a price-to-earnings ratio of -33.29 and a beta of 0.87. The company's 50-day simple moving average is $130.97 and its 200-day simple moving average is $142.40. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.52 and a current ratio of 2.59.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.23 by $0.49. The business had revenue of $599.49 million for the quarter, compared to analysts' expectations of $574.15 million. ICU Medical had a positive return on equity of 6.75% and a negative net margin of 3.87%. The company's quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.96 EPS. As a group, equities research analysts expect that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Institutional Trading of ICU Medical

Institutional investors have recently bought and sold shares of the company. Jennison Associates LLC acquired a new stake in shares of ICU Medical in the fourth quarter worth about $556,000. Equitable Trust Co. lifted its position in shares of ICU Medical by 1.6% during the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after purchasing an additional 84 shares during the last quarter. New York State Teachers Retirement System lifted its position in shares of ICU Medical by 6.7% during the 4th quarter. New York State Teachers Retirement System now owns 28,343 shares of the medical instruments supplier's stock worth $4,398,000 after purchasing an additional 1,777 shares during the last quarter. State of New Jersey Common Pension Fund D lifted its position in shares of ICU Medical by 1.6% during the 4th quarter. State of New Jersey Common Pension Fund D now owns 12,370 shares of the medical instruments supplier's stock worth $1,919,000 after purchasing an additional 191 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its position in shares of ICU Medical by 4.1% during the 4th quarter. Principal Financial Group Inc. now owns 132,099 shares of the medical instruments supplier's stock worth $20,498,000 after purchasing an additional 5,162 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.

Insiders Place Their Bets

In related news, COO Christian B. Voigtlander sold 5,556 shares of the business's stock in a transaction dated Wednesday, May 14th. The stock was sold at an average price of $138.65, for a total transaction of $770,339.40. Following the completion of the transaction, the chief operating officer owned 2,389 shares of the company's stock, valued at approximately $331,234.85. The trade was a 69.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Ben Sousa sold 2,000 shares of the business's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $137.36, for a total value of $274,720.00. Following the transaction, the insider directly owned 479 shares of the company's stock, valued at $65,795.44. This represents a 80.68% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 36,097 shares of company stock worth $4,860,156 over the last quarter. 1.50% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

ICUI has been the topic of a number of recent research reports. KeyCorp decreased their target price on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Wall Street Zen raised ICU Medical from a "hold" rating to a "buy" rating in a research note on Sunday, May 18th. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Finally, Raymond James Financial decreased their price objective on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a research report on Friday, May 9th. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $192.67.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.